Licenciado

Magazine | This Week's News | E-products | Events | Contact us | My Ihe

Breast angiography
Breast angiography
GE

Healthcare’s

new

SenoBright1

Contrast

EnhancedSpectral Mammography (CESM) technology is designed to
allow physicians to image blood flow through angiography of
the breast using a contrast agent and a dual energy
acquisitiontechnique. Contrast agents can be used to
highlight angiogenesis, the growth of small blood vessels
potentially related to the presence of cancer. In addition to
typical mammography imagesthat show breast tissue density,
CESM technology is designed to provide doctors with images
of contrast uptake, which may indicate angiogenesis.
SenoBright uses X-rays at multipleenergies to create two
separate exposures. These resulting images specifically
illuminate and highlight areas where there is contrast uptake
and potentially angiogenesis. As mammographymainly
images tissue densities, SenoBright has been designed to
produce an image that maps contrast uptake, adding the
functional information to the conventional standard tissuedensity information of mammography. Doctors can highlight
the proliferation of small blood vessels, potentially associated
with

cancerous

tumour

growth.

Patients

receivean

intravenous injection of standard iodine contrast agent, and
after two minutes undergo a five-minute digital mammography
exam.
GE Healthcare
283 rue de la Miniere
F-78530 BucFRANCE
Tel.: +33-1-30704040
Fax: +33-1-30709855

Copyright © 2004-2010 - Rue Royale 326, B-1030 Brussels - Tel:+32-2-240 26 11 - Fax:+32-2-240 26 18
IHE and Panglobal are notresponsible for any error or omission that could take place in the electronic display
of product or company Data. This pdf was generated on 04/10/2012 at 14:37:31. Powered by Studio-Web